Immunotherapy in metastatic urothelial carcinoma
1,317 views · Published 16 December 2016 · 5:48 · Indexed 10 November 2026
Channel: The Lancet · 2016 · Science & Technology
Dr Arjun Balar discusses the key results from the study and the possible role of immunotherapy agents, such as atezolizumab, as first-line options in cisplatin-ineligible metastatic urothelial cancer to improve patient outcomes. Published: December 7, 2016 Read the published article at: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)32455-2/fulltext
